Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-230-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-02-16"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"lt"^^xsd:language2
lpv:document identification number	"en.20110216.11.3-230-000"2
lpv:hasSubsequent	lp_eu:2011-02-16-Speech-3-231-0002
lpv:speaker	lp:Rolandas Paksas2
lpv:spokenAs	vice-chair_member_of_the_bureau; EFD (2010-02-16--2012-01-26)3 member; Delegation for relations with the People's Republic of China (2009-09-16--2014-06-30)3 member; PETI (2009-07-16--2012-01-18)3 member; Special Committee on the Financial, Economic and Social Crisis (2009-10-08--2011-07-31)3 unknown; Partija Tvarka ir teisingumas (2009-07-14--2014-06-30)3 member; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees, and for relations with Tajikistan, Turkmenistan and Mongolia (2009-09-16--2014-06-30)3 member; ECON (2009-07-16--2012-01-18)3 substitute; ITRE (2009-07-16--2012-01-18)3
lpv:translated text	"I voted in favour of this resolution because the counterfeiting of medicinal products is a significant problem throughout the EU, and we therefore need to take radical measures to ensure that counterfeit medicines, which could have adverse effects on human health or even life, do not enter the market. We must ensure that only safe and effective medicines reach consumers, and we must stop criminal gangs profiting from counterfeit medicines. We must make every effort to ensure that a strict labelling system for prescription medicines is in force in the EU, including safety labels that establish the manufacturer and supplier. I feel that there should be harsher penalties for medicine counterfeiters, and the control mechanism must operate effectively across the whole of the EU, including every link in the medicine supply chain. Particular attention and safety measures must be devoted to the sale of medicines on the Internet, establishing strict licensing, monitoring and control systems. Every Member State must take all the measures necessary to ensure the effective functioning of a system that warns the public about dangerous counterfeit or low quality medicines and even creates opportunities to remove such medicines from the market."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph